Login to Your Account

Searching for cures, lawmakers look to PCAST report

By Mari Serebrov
Washington Editor

Tuesday, May 20, 2014
Adequate FDA resources and a greater commitment at the agency to consider expedited approval paths early in drug development would go a long way in advancing cures for rare diseases and other medical conditions, a House subcommittee was told Tuesday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription